A Comparative Assessment of Smart Nanoselenium Hybrid Plurosomes for Augmenting Repaglinide Delivery Against Breast and Liver Cancer Treatment: D-Optimal Statistical Design, In Vitro Cytotoxicity, Biomarkers Assessment, and In Silico Studies
Background/Objectives: Nanotherapeutics integrated with drug repurposing represent an emerging approach to overcome ongoing cancer treatment resistance, particularly in breast cancer (BC) and hepatoblastoma (HB). This study comparatively evaluated an optimally designed smart anticancer nanoselenium hybrid repaglinide (...